Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://ellaeesa935971.blue-blogs.com/46852213/trelaglutide-exploring-a-new-therapy-for-chronic-diseases